Capital Research Global Investors
CAH icon

Capital Research Global Investors’s Cardinal Health CAH Stock Holding History

Capital Research Global Investors’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-905,000
Closed -$62M – 446
2014
Q2 		$62M Hold
905,000
– – 0.02% 330
2014
Q1 		$63.3M Hold
905,000
– – 0.02% 322
2013
Q4 		$60.5M Hold
905,000
– – 0.02% 323
2013
Q3 		$47.2M Hold
905,000
– – 0.02% 343
2013
Q2 		$42.7M Buy
+905,000
New +$41.3M 0.02% 333

Other funds holding CAH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital Research Global Investors's CAH Position: Q3 2014 in Review

Capital Research Global Investors sold out of Cardinal Health (CAH) in Q3 2014, closing a stake of 905,000 shares — an estimated $62M sold.

Capital Research Global Investors first reported a position in CAH in Q2 2013 and held it in 5 quarters. The position peaked at $63.3M in Q1 2014. 643 funds tracked by Wall St. Rank hold CAH as of Q3 2014.

  • Capital Research Global Investors reported no remaining Cardinal Health position as of Q3 2014 after selling out during the quarter.
  • Capital Research Global Investors sold 905,000 Cardinal Health shares in Q3 2014, an estimated $62M.
  • Capital Research Global Investors first reported a position in Cardinal Health in Q2 2013 and held it in 5 quarters.
  • Capital Research Global Investors's Cardinal Health position peaked at $63.3M in Q1 2014.
  • 643 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2014.

Based on Capital Research Global Investors's 13F filing for Q3 2014, filed 14 Nov 2014.